Lynx Biosciences is a biotechnology company developing therapies and drug-discovery insights using patient-derived ex vivo disease models and integrated multi-omics
Lynx Biosciences is a biotechnology company developing therapies and drug-discovery insights using patient-derived ex vivo disease models and integrated multi-omics. Its platform profiles therapeutic activity in tumor and immune microenvironments, identifies biomarkers and resistance mechanisms, and supports translational research in immuno-oncology and immunology.